Taiwan FDA registration 60c7f445234d8b585c10e2170362255c

"Siemens" immunoglobulin G analysis reagent

TW: “西門子” 免疫球蛋白G分析試劑

Taiwan·Risk Class 2·RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.·Registered Nov 02, 2018 – Nov 02, 2028Active

Registration details

Analysis ID: 60c7f445234d8b585c10e2170362255c
Customs Code: DHA05603177203

Company information

Manufacturer: RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.
Manufacturer Country: United Kingdom;;United States
Authorized Representative: SIEMENS HEALTHCARE LIMITED

Product details

Intended Use: This product is used in vitro diagnostics with Atellica CH Analyzer to quantitatively detect immunoglobulin G (IgG) in human serum and plasma (heparin lithium).
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
Import Information: import

Dates and status

Registration Date: Nov 02, 2018
Expiry Date: Nov 02, 2028

About this record

Access comprehensive regulatory information for "Siemens" immunoglobulin G analysis reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 60c7f445234d8b585c10e2170362255c and manufactured by RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.